デジタルバイオマーカーの世界市場 2024-2028

概要

デジタルバイオマーカー市場は2023-2028年に44億2,971万米ドル、予測期間中のCAGRは21.04%で成長すると予測されます。

当レポートでは、デジタルバイオマーカー市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。神経疾患の有病率の増加、CVDの有病率の増加、スマートウェアラブルの採用増加などが市場を牽引しています。

当レポートでは、今後数年間のデジタルバイオマーカー市場成長を牽引する主要因の1つとして、個別化治療への注目の高まりを挙げています。また、各国での臨床試験の増加や遠隔健康モニタリングの需要拡大も、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• デジタルバイオマーカーの世界市場 2018-2022
• エンドユーザー別セグメント分析 2018-2022
• タイプ別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 医療企業：市場規模と予測 2023-2028
• 医療提供者：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：エンドユーザー別

第7章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• ウェアラブル：市場規模と予測 2023-2028
• モバイルアプリ：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：タイプ別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 市場機会：地域別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Alphabet Inc.
• Altoida Inc
• Aural Analytics Inc
• Brainomix Ltd.
• Chugai Pharmaceutical Co. Ltd.
• Clinical Ink Inc.
• Empatica Inc.
• eResearchTechnology GmbH
• F. Hoffmann La Roche Ltd.
• IQVIA Holdings Inc.
• IXICO plc
• Koneksa Health Inc.
• Neurotrack Technologies Inc.
• PureTech Health Plc
• VivoSense Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global digital biomarkers market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on End-user - Market share 2023-2028 (%)
• Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by End-user
• Exhibits33: Data Table on Comparison by End-user
• Exhibits34: Chart on Healthcare companies - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Healthcare companies - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Healthcare companies - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Healthcare companies - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Healthcare providers - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Healthcare providers - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Healthcare providers - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Healthcare providers - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by End-user ($ million)
• Exhibits47: Data Table on Market opportunity by End-user ($ million)
• Exhibits48: Chart on Type - Market share 2023-2028 (%)
• Exhibits49: Data Table on Type - Market share 2023-2028 (%)
• Exhibits50: Chart on Comparison by Type
• Exhibits51: Data Table on Comparison by Type
• Exhibits52: Chart on Wearables - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Wearables - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Wearables - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Wearables - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Mobile application - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Mobile application - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Mobile application - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Mobile application - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits64: Market opportunity by Type ($ million)
• Exhibits65: Data Table on Market opportunity by Type ($ million)
• Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits67: Chart on Market share by geography 2023-2028 (%)
• Exhibits68: Data Table on Market share by geography 2023-2028 (%)
• Exhibits69: Chart on Geographic comparison
• Exhibits70: Data Table on Geographic comparison
• Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits107: Market opportunity by geography ($ million)
• Exhibits108: Data Tables on Market opportunity by geography ($ million)
• Exhibits109: Impact of drivers and challenges in 2023 and 2028
• Exhibits110: Overview on Criticality of inputs and Factors of differentiation
• Exhibits111: Overview on factors of disruption
• Exhibits112: Impact of key risks on business
• Exhibits113: Vendors covered
• Exhibits114: Matrix on vendor position and classification
• Exhibits115: Alphabet Inc. - Overview
• Exhibits116: Alphabet Inc. - Business segments
• Exhibits117: Alphabet Inc. - Key news
• Exhibits118: Alphabet Inc. - Key offerings
• Exhibits119: Alphabet Inc. - Segment focus
• Exhibits120: Altoida Inc - Overview
• Exhibits121: Altoida Inc - Product / Service
• Exhibits122: Altoida Inc - Key offerings
• Exhibits123: Aural Analytics Inc - Overview
• Exhibits124: Aural Analytics Inc - Product / Service
• Exhibits125: Aural Analytics Inc - Key offerings
• Exhibits126: Brainomix Ltd. - Overview
• Exhibits127: Brainomix Ltd. - Product / Service
• Exhibits128: Brainomix Ltd. - Key offerings
• Exhibits129: Chugai Pharmaceutical Co. Ltd. - Overview
• Exhibits130: Chugai Pharmaceutical Co. Ltd. - Product / Service
• Exhibits131: Chugai Pharmaceutical Co. Ltd. - Key offerings
• Exhibits132: Clinical Ink Inc. - Overview
• Exhibits133: Clinical Ink Inc. - Product / Service
• Exhibits134: Clinical Ink Inc. - Key offerings
• Exhibits135: Empatica Inc. - Overview
• Exhibits136: Empatica Inc. - Product / Service
• Exhibits137: Empatica Inc. - Key offerings
• Exhibits138: eResearchTechnology GmbH - Overview
• Exhibits139: eResearchTechnology GmbH - Product / Service
• Exhibits140: eResearchTechnology GmbH - Key offerings
• Exhibits141: F. Hoffmann La Roche Ltd. - Overview
• Exhibits142: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits143: F. Hoffmann La Roche Ltd. - Key news
• Exhibits144: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits145: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits146: IQVIA Holdings Inc. - Overview
• Exhibits147: IQVIA Holdings Inc. - Business segments
• Exhibits148: IQVIA Holdings Inc. - Key news
• Exhibits149: IQVIA Holdings Inc. - Key offerings
• Exhibits150: IQVIA Holdings Inc. - Segment focus
• Exhibits151: IXICO plc - Overview
• Exhibits152: IXICO plc - Product / Service
• Exhibits153: IXICO plc - Key offerings
• Exhibits154: Koneksa Health Inc. - Overview
• Exhibits155: Koneksa Health Inc. - Product / Service
• Exhibits156: Koneksa Health Inc. - Key offerings
• Exhibits157: Neurotrack Technologies Inc. - Overview
• Exhibits158: Neurotrack Technologies Inc. - Product / Service
• Exhibits159: Neurotrack Technologies Inc. - Key offerings
• Exhibits160: PureTech Health Plc - Overview
• Exhibits161: PureTech Health Plc - Business segments
• Exhibits162: PureTech Health Plc - Key offerings
• Exhibits163: PureTech Health Plc - Segment focus
• Exhibits164: VivoSense Inc. - Overview
• Exhibits165: VivoSense Inc. - Product / Service
• Exhibits166: VivoSense Inc. - Key offerings
• Exhibits167: Inclusions checklist
• Exhibits168: Exclusions checklist
• Exhibits169: Currency conversion rates for US$
• Exhibits170: Research methodology
• Exhibits171: Validation techniques employed for market sizing
• Exhibits172: Information sources
• Exhibits173: List of abbreviations

Abstract

The digital biomarkers market is forecasted to grow by USD 4429.71 mn during 2023-2028, accelerating at a CAGR of 21.04% during the forecast period. The report on the digital biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of neurological disorders, the increasing prevalence of CVDs, and the increasing adoption of smart wearables.

Technavio's digital biomarkers market is segmented as below:

By End-user

• Healthcare companies
• Healthcare providers
• Others

By Type

• Wearables
• Mobile application
• Others

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing focus on personalized treatments as one of the prime reasons driving the digital biomarkers market growth during the next few years. Also, the increasing number of clinical trials in countries and growing demand for remote health monitoring will lead to a sizable demand in the market.

The report on the digital biomarkers market covers the following areas:

• Digital biomarkers market sizing
• Digital biomarkers market forecast
• Digital biomarkers market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading digital biomarkers market vendors that include Alphabet Inc., Altoida Inc, Aural Analytics Inc, Brainomix Ltd., Chugai Pharmaceutical Co. Ltd., Clinical Ink Inc., Empatica Inc. , eResearchTechnology GmbH, EVOCAL Health GmbH, F. Hoffmann La Roche Ltd., IMVARIA Inc., Invitrace, IQVIA Holdings Inc., IXICO plc, Koneksa Health Inc., Neurotrack Technologies Inc., PureTech Health Plc, Science Group Plc., VivoSense Inc., and APPLICARE.AI. Also, the digital biomarkers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global digital biomarkers market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global digital biomarkers market 2018 - 2022 ($ million)
• 4.2 End-user Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.3 Type Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
• 6.2 Comparison by End-user
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user
• 6.3 Healthcare companies - Market size and forecast 2023-2028
• Exhibit 34: Chart on Healthcare companies - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Healthcare companies - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Healthcare companies - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Healthcare companies - Year-over-year growth 2023-2028 (%)
• 6.4 Healthcare providers - Market size and forecast 2023-2028
• Exhibit 38: Chart on Healthcare providers - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Healthcare providers - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Healthcare providers - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Healthcare providers - Year-over-year growth 2023-2028 (%)
• 6.5 Others - Market size and forecast 2023-2028
• Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by End-user
• Exhibit 46: Market opportunity by End-user ($ million)
• Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 48: Chart on Type - Market share 2023-2028 (%)
• Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
• 7.2 Comparison by Type
• Exhibit 50: Chart on Comparison by Type
• Exhibit 51: Data Table on Comparison by Type
• 7.3 Wearables - Market size and forecast 2023-2028
• Exhibit 52: Chart on Wearables - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Wearables - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Wearables - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Wearables - Year-over-year growth 2023-2028 (%)
• 7.4 Mobile application - Market size and forecast 2023-2028
• Exhibit 56: Chart on Mobile application - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Mobile application - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Mobile application - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Mobile application - Year-over-year growth 2023-2028 (%)
• 7.5 Others - Market size and forecast 2023-2028
• Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Type
• Exhibit 64: Market opportunity by Type ($ million)
• Exhibit 65: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share by geography 2023-2028 (%)
• Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
• Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 Canada - Market size and forecast 2023-2028
• Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
• Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity by geography
• Exhibit 107: Market opportunity by geography ($ million)
• Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 Alphabet Inc.
• Exhibit 115: Alphabet Inc. - Overview
• Exhibit 116: Alphabet Inc. - Business segments
• Exhibit 117: Alphabet Inc. - Key news
• Exhibit 118: Alphabet Inc. - Key offerings
• Exhibit 119: Alphabet Inc. - Segment focus
• 12.4 Altoida Inc
• Exhibit 120: Altoida Inc - Overview
• Exhibit 121: Altoida Inc - Product / Service
• Exhibit 122: Altoida Inc - Key offerings
• 12.5 Aural Analytics Inc
• Exhibit 123: Aural Analytics Inc - Overview
• Exhibit 124: Aural Analytics Inc - Product / Service
• Exhibit 125: Aural Analytics Inc - Key offerings
• 12.6 Brainomix Ltd.
• Exhibit 126: Brainomix Ltd. - Overview
• Exhibit 127: Brainomix Ltd. - Product / Service
• Exhibit 128: Brainomix Ltd. - Key offerings
• 12.7 Chugai Pharmaceutical Co. Ltd.
• Exhibit 129: Chugai Pharmaceutical Co. Ltd. - Overview
• Exhibit 130: Chugai Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 131: Chugai Pharmaceutical Co. Ltd. - Key offerings
• 12.8 Clinical Ink Inc.
• Exhibit 132: Clinical Ink Inc. - Overview
• Exhibit 133: Clinical Ink Inc. - Product / Service
• Exhibit 134: Clinical Ink Inc. - Key offerings
• 12.9 Empatica Inc.
• Exhibit 135: Empatica Inc. - Overview
• Exhibit 136: Empatica Inc. - Product / Service
• Exhibit 137: Empatica Inc. - Key offerings
• 12.10 eResearchTechnology GmbH
• Exhibit 138: eResearchTechnology GmbH - Overview
• Exhibit 139: eResearchTechnology GmbH - Product / Service
• Exhibit 140: eResearchTechnology GmbH - Key offerings
• 12.11 F. Hoffmann La Roche Ltd.
• Exhibit 141: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 142: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 143: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 144: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 145: F. Hoffmann La Roche Ltd. - Segment focus
• 12.12 IQVIA Holdings Inc.
• Exhibit 146: IQVIA Holdings Inc. - Overview
• Exhibit 147: IQVIA Holdings Inc. - Business segments
• Exhibit 148: IQVIA Holdings Inc. - Key news
• Exhibit 149: IQVIA Holdings Inc. - Key offerings
• Exhibit 150: IQVIA Holdings Inc. - Segment focus
• 12.13 IXICO plc
• Exhibit 151: IXICO plc - Overview
• Exhibit 152: IXICO plc - Product / Service
• Exhibit 153: IXICO plc - Key offerings
• 12.14 Koneksa Health Inc.
• Exhibit 154: Koneksa Health Inc. - Overview
• Exhibit 155: Koneksa Health Inc. - Product / Service
• Exhibit 156: Koneksa Health Inc. - Key offerings
• 12.15 Neurotrack Technologies Inc.
• Exhibit 157: Neurotrack Technologies Inc. - Overview
• Exhibit 158: Neurotrack Technologies Inc. - Product / Service
• Exhibit 159: Neurotrack Technologies Inc. - Key offerings
• 12.16 PureTech Health Plc
• Exhibit 160: PureTech Health Plc - Overview
• Exhibit 161: PureTech Health Plc - Business segments
• Exhibit 162: PureTech Health Plc - Key offerings
• Exhibit 163: PureTech Health Plc - Segment focus
• 12.17 VivoSense Inc.
• Exhibit 164: VivoSense Inc. - Overview
• Exhibit 165: VivoSense Inc. - Product / Service
• Exhibit 166: VivoSense Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 167: Inclusions checklist
• Exhibit 168: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 169: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 170: Research methodology
• Exhibit 171: Validation techniques employed for market sizing
• Exhibit 172: Information sources
• 13.5 List of abbreviations
• Exhibit 173: List of abbreviations